- Home
- COEP vs SCNX Comparison
COEP vs SCNX Comparison
Compare COEP & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- SCNX
- Stock Information
- Founded
- COEP 2017
- SCNX 2010
- Country
- COEP United States
- SCNX United States
- Employees
- COEP N/A
- SCNX N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- SCNX Other Pharmaceuticals
- Sector
- COEP Health Care
- SCNX Health Care
- Exchange
- COEP Nasdaq
- SCNX Nasdaq
- Market Cap
- COEP 62.4M
- SCNX 21.2M
- IPO Year
- COEP N/A
- SCNX 2020
- Fundamental
- Price
- COEP $12.60
- SCNX $0.86
- Analyst Decision
- COEP
- SCNX
- Analyst Count
- COEP 0
- SCNX 0
- Target Price
- COEP N/A
- SCNX N/A
- AVG Volume (30 Days)
- COEP 39.1K
- SCNX 475.0K
- Earning Date
- COEP 11-12-2025
- SCNX 11-05-2025
- Dividend Yield
- COEP N/A
- SCNX N/A
- EPS Growth
- COEP N/A
- SCNX N/A
- EPS
- COEP N/A
- SCNX N/A
- Revenue
- COEP $263,555.00
- SCNX $128,202.00
- Revenue This Year
- COEP N/A
- SCNX N/A
- Revenue Next Year
- COEP N/A
- SCNX N/A
- P/E Ratio
- COEP N/A
- SCNX N/A
- Revenue Growth
- COEP N/A
- SCNX N/A
- 52 Week Low
- COEP $2.31
- SCNX $0.69
- 52 Week High
- COEP $14.70
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- COEP 51.40
- SCNX 31.19
- Support Level
- COEP $12.09
- SCNX $0.86
- Resistance Level
- COEP $13.25
- SCNX $1.16
- Average True Range (ATR)
- COEP 0.73
- SCNX 0.09
- MACD
- COEP -0.12
- SCNX 0.02
- Stochastic Oscillator
- COEP 45.78
- SCNX 10.51
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.